155 related articles for article (PubMed ID: 11315098)
21. Inhibitory effect of panduratin A on c-Jun N-terminal kinase and activator protein-1 signaling involved in Porphyromonas gingivalis supernatant-stimulated matrix metalloproteinase-9 expression in human oral epidermoid cells.
Yanti ; Lee M; Kim D; Hwang JK
Biol Pharm Bull; 2009 Oct; 32(10):1770-5. PubMed ID: 19801842
[TBL] [Abstract][Full Text] [Related]
22. Erk 1/2 differentially regulates the expression from the 1G/2G single nucleotide polymorphism in the MMP-1 promoter in melanoma cells.
Tower GB; Coon CC; Benbow U; Vincenti MP; Brinckerhoff CE
Biochim Biophys Acta; 2002 Apr; 1586(3):265-74. PubMed ID: 11997078
[TBL] [Abstract][Full Text] [Related]
23. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade.
Lengyel E; Wang H; Gum R; Simon C; Wang Y; Boyd D
Oncogene; 1997 May; 14(21):2563-73. PubMed ID: 9191056
[TBL] [Abstract][Full Text] [Related]
24. IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork.
Hosseini M; Rose AY; Song K; Bohan C; Alexander JP; Kelley MJ; Acott TS
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1469-76. PubMed ID: 16565381
[TBL] [Abstract][Full Text] [Related]
25. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Cheung LW; Leung PC; Wong AS
Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
[TBL] [Abstract][Full Text] [Related]
26. Glycitein inhibits glioma cell invasion through down-regulation of MMP-3 and MMP-9 gene expression.
Lee EJ; Kim SY; Hyun JW; Min SW; Kim DH; Kim HS
Chem Biol Interact; 2010 Apr; 185(1):18-24. PubMed ID: 20188714
[TBL] [Abstract][Full Text] [Related]
27. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS
Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534
[TBL] [Abstract][Full Text] [Related]
28. Naringin suppresses cell metastasis and the expression of matrix metalloproteinases (MMP-2 and MMP-9) via the inhibition of ERK-P38-JNK signaling pathway in human glioblastoma.
Aroui S; Aouey B; Chtourou Y; Meunier AC; Fetoui H; Kenani A
Chem Biol Interact; 2016 Jan; 244():195-203. PubMed ID: 26721195
[TBL] [Abstract][Full Text] [Related]
29. Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression.
Crowe DL; Tsang KJ; Shemirani B
Neoplasia; 2001; 3(1):27-32. PubMed ID: 11326313
[TBL] [Abstract][Full Text] [Related]
30. Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells.
Nagata T; Kai H; Shibata R; Koga M; Yoshimura A; Imaizumi T
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):588-93. PubMed ID: 12615664
[TBL] [Abstract][Full Text] [Related]
31. Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells.
Yao J; Xiong S; Klos K; Nguyen N; Grijalva R; Li P; Yu D
Oncogene; 2001 Dec; 20(56):8066-74. PubMed ID: 11781819
[TBL] [Abstract][Full Text] [Related]
32. Glial cell-induced endothelial morphogenesis is inhibited by interfering with extracellular signal-regulated kinase signaling.
Chandrasekar N; Mohanam S; Lakka SS; Dinh DH; Olivero WC; Gujrati M; Rao JS
Clin Cancer Res; 2003 Jun; 9(6):2342-9. PubMed ID: 12796404
[TBL] [Abstract][Full Text] [Related]
33. p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression.
Westermarck J; Li SP; Kallunki T; Han J; Kähäri VM
Mol Cell Biol; 2001 Apr; 21(7):2373-83. PubMed ID: 11259586
[TBL] [Abstract][Full Text] [Related]
34. Essential role for ERK mitogen-activated protein kinase in matrix metalloproteinase-9 regulation in rat cortical astrocytes.
Arai K; Lee SR; Lo EH
Glia; 2003 Sep; 43(3):254-64. PubMed ID: 12898704
[TBL] [Abstract][Full Text] [Related]
35. Transforming growth factor-beta1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells.
Kwak HJ; Park MJ; Cho H; Park CM; Moon SI; Lee HC; Park IC; Kim MS; Rhee CH; Hong SI
Mol Cancer Res; 2006 Mar; 4(3):209-20. PubMed ID: 16547158
[TBL] [Abstract][Full Text] [Related]
36. Resveratrol suppresses TPA-induced matrix metalloproteinase-9 expression through the inhibition of MAPK pathways in oral cancer cells.
Lin FY; Hsieh YH; Yang SF; Chen CT; Tang CH; Chou MY; Chuang YT; Lin CW; Chen MK
J Oral Pathol Med; 2015 Oct; 44(9):699-706. PubMed ID: 25401496
[TBL] [Abstract][Full Text] [Related]
37. Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells.
Cho A; Graves J; Reidy MA
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2527-32. PubMed ID: 11116048
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential.
Chung TW; Lee YC; Kim CH
FASEB J; 2004 Jul; 18(10):1123-5. PubMed ID: 15132991
[TBL] [Abstract][Full Text] [Related]
39. Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells.
Das G; Shiras A; Shanmuganandam K; Shastry P
Mol Carcinog; 2011 Jun; 50(6):412-23. PubMed ID: 21557327
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components.
Schuringa JJ; Jonk LJ; Dokter WH; Vellenga E; Kruijer W
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):89-96. PubMed ID: 10727406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
